Vospalitel'nye zabolevaniya organov malogo taza: sovremennaya taktika terapii


Cite item

Full Text

Abstract

About the authors

A V Shurshalina

References

  1. Boeke AJ. The risk of pelvic inflammatory disease with urogenital infection with Chlamydia trachomatis. Ned Tijdschr Geneeskd 2005; 16 (149): 878-84.
  2. CDC. Sexually Transmitted Disease Treatment Guidelines. Pelvic Inflammatory Disease. MMWR 2010; 59: RR-12.
  3. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765-6.
  4. RCOG Green Top Guidelines-Management of Pelvic Inflammatory Disease (2003, 2009) (www.rcog.org.uk)
  5. Clarke LM, Duerr А, Yeung КН. Recovery of cytomegalovirus and herpes simplex virus from upper and lower genital tract specimens obtained from women with pelvic inflammatory disease. J Infect Dis 1997; 1 (176): 286-8.
  6. Cohen CR. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359: 765-6.
  7. Гинекология: национальное руководство. Под ред. В.И.Кулакова, И.Б.Манухина, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2011.
  8. Jaiyeoba O, Soper DE. A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol 2011; 753037.
  9. Blake DR. Identification of symptoms that indicate a pelvic examination is necessary to exclude PID in adolescent women. J Pediatr Adolesc Gynecol 2003; 1 (16): 25-30.
  10. Korn AP. Risk factors for plasma cell endometritis among women with cervical Chlamydia trachomatis, cervical Neisseria gonorrhoeae, or bacterial vaginosis. Am J Obstet Gynecol 1998; 5 (178): 987-90.
  11. Lin HW, Tu YY, Lin SY. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 2011; 12 (9): 900-4.
  12. Hillis SD, Joesoef R, Marchbanks PA et al. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 163: 1503-9.
  13. Практическое руководство по антиинфекционной химиотерапии. Под ред. Л.С.Страчунского, Ю.Б.Белоусова, С.Н.Козлова. М., 2002.
  14. Ness RB, Soper DE, Holley RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trail. American J Obstet Gynecol 2002; 186: 929-37.
  15. Ross JD. Outpatient antibiotics for pelvic inflammatory disease. BMJ 2001; 322: 251-2.
  16. Low N, Welch J, Radcliff K. Developing national outcome standards for the management of gonorrhea and genital Chlamydia in genitourinary medicine clinics. Sex Trans Infect 2004; 80: 223-9.
  17. Shih TY, Gaydos CA, Rothman RE. Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease. Sex Trans Dis 2011; 38 (4): 299-305.
  18. Jaiyeoba O, Lazenby G, Soper DE. Recommendations and rationale for the treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2011; 9 (1): 61-70.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-63961 от 18.12.2015.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies